Latest Period
Q4 2025
Security Snapshot
Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) Institutional Ownership
CUSIP: 13463J101
13F Institutional Holders and Ownership History from Q4 2024 to Q1 2026
Institutions Reporting
39
Shares (Excl. Options)
38,247,378
Price
$6.13
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- CAMP on Nasdaq
- Shares outstanding
- 51,990,875
- Price per share
- $4.49
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 38,247,378
- Total reported value
- $234,599,194
- % of total 13F portfolios
- 0%
- Share change
- +8,053,354
- Value change
- +$51,453,984
- Number of holders
- 39
- Price from insider filings
- $4.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share is tracked under CUSIP 13463J101.
- 39 institutions reported positions in Q4 2025.
- 10 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 39 to 12 between Q4 2025 and Q1 2026.
- Reported value moved from $234,599,194 to $10,143,370.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 39 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 13463J101?
CUSIP 13463J101 identifies CAMP - Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 13463J101:
Significant Owners of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 12% | $37,908,892 | 6,307,636 | JANUS HENDERSON GROUP PLC | 31 Dec 2025 | |||
| 5AM Ventures VI, L.P. | 12% | $8,392,800 | 5,869,091 | Andrew J. Schwab | 09 Sep 2025 | |||
| FMR LLC | 9.5% | +40% | $28,968,451 | +$10,440,496 | 4,918,243 | +56% | FMR LLC | 31 Dec 2025 |
| Coastlands Capital LP | 10% | $21,452,710 | 4,886,722 | Coastlands Capital LP | 10 Sep 2025 | |||
| Polaris Management Co. VII, L.L.C. | 8.4% | $5,623,119 | 3,932,251 | Amir Nashat | 09 Sep 2025 | |||
| Vivo Opportunity Fund Holdings, L.P. | 7.4% | -2.5% | $23,373,365 | +$1,788,900 | 3,856,991 | +8.3% | Vivo Opportunity Fund Holdings, L.P. | 31 Dec 2025 |
| Enavate Sciences GP, LLC | 4.8% | -20% | $10,955,517 | -$2,773,593 | 2,495,562 | -20% | Enavate Sciences GP, LLC | 09 Mar 2026 |
| Northpond Ventures II, LP | 4.8% | $6,714,732 | 2,238,244 | Michael P. Rubin | 30 Sep 2025 | |||
| AH Bio Fund I, L.P. | 4.5% | $6,376,017 | 2,125,339 | Marc L. Andreessen | 30 Sep 2025 | |||
| HARBOURVEST PARTNERS LLC | 2.7% | -60% | $3,536,015 | 1,271,948 | 0% | HarbourVest Partners L.P. | 30 Sep 2025 |
As of 31 Dec 2025, 39 institutional investors reported holding 38,247,378 shares of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP). This represents 74% of the company’s total 51,990,875 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 12% | 6,307,636 | +36% | 0.02% | $38,807,475 |
| 5AM Venture Management, LLC | 11% | 5,869,091 | 0% | 11% | $35,977,528 |
| FMR LLC | 9.5% | 4,918,243 | +63% | 0% | $30,148,830 |
| Vivo Capital, LLC | 8.2% | 4,246,568 | +8.3% | 1.7% | $26,031,462 |
| ENAVATE SCIENCES GP, LLC | 5.8% | 3,035,825 | -20% | 3.7% | $18,609,607 |
| Balyasny Asset Management L.P. | 4.7% | 2,436,900 | 0.03% | $14,938,197 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.2% | 2,181,679 | +11% | 0.02% | $13,373,692 |
| a16z Capital Management, L.L.C. | 4.1% | 2,125,339 | 0% | 0.82% | $13,028,328 |
| Trails Edge Capital Partners, LP | 3.8% | 1,983,986 | 0% | 3% | $12,161,834 |
| VANGUARD GROUP INC | 3.2% | 1,672,960 | +434% | 0% | $10,255,245 |
| HarbourVest Partners LLC | 2.4% | 1,271,948 | 0% | 4.5% | $7,797,041 |
| BlackRock, Inc. | 0.75% | 390,160 | +3311% | 0% | $2,391,681 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.65% | 336,293 | +457% | 0% | $2,062,578 |
| EcoR1 Capital, LLC | 0.63% | 325,000 | 0.09% | $1,992,250 | |
| Stonepine Capital Management, LLC | 0.44% | 228,894 | 1.1% | $1,403,120 | |
| Alyeska Investment Group, L.P. | 0.38% | 200,000 | 0% | 0% | $1,226,000 |
| 683 Capital Management, LLC | 0.24% | 126,363 | 0.06% | $774,605 | |
| TWO SIGMA INVESTMENTS, LP | 0.18% | 94,531 | -2.9% | 0% | $579,475 |
| VICTORY CAPITAL MANAGEMENT INC | 0.16% | 82,790 | 0% | 0% | $507,503 |
| NORTHERN TRUST CORP | 0.14% | 74,509 | +410% | 0% | $456,740 |
| BARCLAYS PLC | 0.14% | 73,601 | +105044% | 0% | $451,174 |
| STATE STREET CORP | 0.08% | 39,700 | +53% | 0% | $243,361 |
| ExodusPoint Capital Management, LP | 0.07% | 34,720 | 0% | $212,834 | |
| JANE STREET GROUP, LLC | 0.05% | 25,534 | 0% | $156,523 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.05% | 25,000 | 0% | 0% | $153,250 |
Institutional Holders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,300,084 | $10,143,370 | +$178,892 | $4.41 | 12 |
| 2025 Q4 | 38,247,378 | $234,599,194 | +$51,453,984 | $6.13 | 39 |
| 2025 Q3 | 28,210,083 | $84,630,390 | +$49,505,803 | $3.00 | 28 |
| 2025 Q2 | 11,744,129 | $17,029,220 | -$3,217,598 | $1.45 | 28 |
| 2025 Q1 | 12,677,488 | $50,710,355 | -$1,002,366 | $4.00 | 39 |
| 2024 Q4 | 12,854,057 | $67,096,861 | +$47,332,167 | $5.22 | 36 |